Vascular Surgery Associates LLC   Report issue

Academic/Hospital Phase 3
Founded: Abingdon MD United States (1987)

Organization Overview

First Clinical Trial
2003
NCT00067119
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

Vascular Surgery Associates LLC

Active Ingredients

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fistula (Phase 3)

Renal Insufficiency (Phase 3)

Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2